Owners, management and financials
CVR: 37770426
Secondary names: Right Level Pharma Consult ApS
DKK 1,249,151
Gross profit
Net result: DKK 247,464
AVP Holdings ApS (100%)
CVR · view owners
Anders Vagnø Pedersen
CVR · view management
Active
Founded 1 June 2016
CVR · view overview
1 employee
CVR · 2018
Director registered: Anders Vagnø Pedersen
CVR · 01/06/2016
View the full event history
AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.
Source: annual report 2025, Danish Business Authority
The financial health of AVP BioPharma Consult ApS appears stable, with a consistent gross profit trend over the past five years, peaking at 1,249,151 DKK in 2025. Profitability has shown a positive trajectory, increasing from 106,199 DKK in 2023 to 247,464 DKK in 2025, indicating effective cost management and operational efficiency. However, the company's equity has slightly declined from 345,697 DKK in 2021 to 320,541 DKK in 2025, which may raise concerns about long-term financial stability. Operating in the research and experimental development sector, the company is positioned to leverage its expertise, although the lack of disclosed revenue could limit visibility into overall market performance.
AI-generated summary · Generated 13/08/2026
Selskabets formål er at levere konsulent- og serviceydelser til interesser, som driver forskning og udvikling rettet mod fremstilling og kommercialisering af lægemidler, medicinsk udstyr og/eller kosttilskud, og andre hermed relaterede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.2 mio. | 247 t. | 444 t. | 321 t. | 1 | |
| 202401/01/2024 – 31/12/2024 | 1.2 mio. | 238 t. | 504 t. | 323 t. | 1 | |
| 202301/01/2023 – 31/12/2023 | 1 mio. | 106 t. | 387 t. | 225 t. | 1 | |
| 202201/01/2022 – 31/12/2022 | 1.1 mio. | 148 t. | 498 t. | 294 t. | 1 | |
| 202101/01/2021 – 31/12/2021 | 1.2 mio. | 261 t. | 516 t. | 346 t. | 1 | |
| 202001/01/2020 – 31/12/2020 | 1.1 mio. | 190 t. | 479 t. | 295 t. | 1 | |
| 201901/01/2019 – 31/12/2019 | 1.5 mio. | 320 t. | 480 t. | 375 t. | 1 | |
| 201801/01/2018 – 31/12/2018 | 1 mio. | 71 t. | 325 t. | 126 t. | 1 | |
| 201701/01/2017 – 31/12/2017 | 1.1 mio. | 58 t. | 273 t. | 142 t. | 1 |
Compared to 1.039 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of AVP BioPharma Consult ApS is 37770426.
AVP BioPharma Consult ApS is owned by AVP Holdings ApS.
The management of AVP BioPharma Consult ApS consists of Anders Vagnø Pedersen.
In 2025, AVP BioPharma Consult ApS reported a gross profit of DKK 1,249,151.
AVP BioPharma Consult ApS had 1 employee in 2018 according to the Danish CVR register.
AVP BioPharma Consult ApS was founded on 1 June 2016.
Claim this page to add your logo and social links. Free to get started.
AVP BioPharma Consult ApS has published its annual report for 2025. Gross profit came to DKK 1,249,151, and the net result was DKK 247,464.
AVP BioPharma Consult ApS has published its annual report for 2024. Gross profit came to DKK 1,169,184, and the net result was DKK 237,789.
AVP BioPharma Consult ApS has published its annual report for 2023. Gross profit came to DKK 1,008,640, and the net result was DKK 106,199.
AVP BioPharma Consult ApS has published its annual report for 2022. Gross profit came to DKK 1,125,468, and the net result was DKK 148,392.
AVP BioPharma Consult ApS has published its annual report for 2021. Gross profit came to DKK 1,201,153, and the net result was DKK 260,721.
AVP BioPharma Consult ApS has published its annual report for 2020. Gross profit came to DKK 1,106,641, and the net result was DKK 189,764.
AVP BioPharma Consult ApS has published its annual report for 2019. Gross profit came to DKK 1,462,906, and the net result was DKK 319,722.
AVP BioPharma Consult ApS has published its annual report for 2018. Gross profit came to DKK 1,004,674, and the net result was DKK 71,232.
AVP BioPharma Consult ApS has published its annual report for 2017. Gross profit came to DKK 1,089,445, and the net result was DKK 57,529.
AVP BioPharma Consult ApS has published its interim report for the period June 1, 2016 – December 31, 2016.
As of June 1, 2016, Anders Vagnø Pedersen is registered as adm. dir. of AVP BioPharma Consult ApS.
As of June 1, 2016, AVP Holdings ApS is registered as an owner of AVP BioPharma Consult ApS with an ownership share of 100%.
AVP BioPharma Consult ApS was founded on June 1, 2016.
Companies in the same industry and area
CVR 31348854
CVR 40128549
CVR 40378030
CVR 31741459
CVR 44993171
